Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: Evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines

British Journal of Pharmacology

Volumn 120, Issue 6, 1997, Pages 1119-1127

  Gniadecki, Robert ^a,b  

^a Leo Pharmaceutical Products ^*  (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cytokines; Differentiation; Keratinocyte; Stem cell; Vitamin D; Vitamin D analogues

Indexed keywords

CALCITRIOL; CALCITRIOL DERIVATIVE; CYTOKINE; EPIDERMAL GROWTH FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INVOLUCRIN; KERATIN; KERATINOCYTE GROWTH FACTOR; LEXACALCITOL; MC 1301; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; EPIDERMIS HYPERPLASIA; HUMAN; HUMAN CELL; KERATINOCYTE; MITOSIS RATE; PHENOTYPE; PRIORITY JOURNAL; PSORIASIS; STEM CELL;

CALCITRIOL; CALCIUM; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CYTOKINES; GROWTH SUBSTANCES; HUMANS; KERATINOCYTES; STEM CELLS;

EID: 0030902662     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701015     Document Type: Article

References (60)

1. AVIVI, A., ZIMMER, Y., YAYON, A., YARDEN, Y. & GIVOL, D. (1991). Flg-2, a new member of the family of fibroblast growth factor receptors. Oncogene, 6, 1089-1092.
2. BARRANDON, Y. & GREEN, H. (1987). Three clonal types of keratinocyte with different capacities for multiplication. Proc. Natl. Acad. Sci. U.S.A., 84, 2302-2306.
3. BARSONY, J. & MARX, S.J. (1991). Rapid accumulation of cyclic GMP near activated vitamin D receptors. Proc. Natl. Acad. Sci. U.S.A., 88, 1436-1440.
4. BATA-CSORGO, Z., HAMMERBERG, C., VOORHEES, J.J. & COOPER, K.D. (1993). Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis. J. Exp. Med., 178, 1271-1281.
5. BATA-CSORGO, Z., HAMMERBERG, C., VOORHEES, J.J. & COOPER, K.D. (1995). Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J. Clin. Invest., 95, 317-327.
6. BIKLE, D.D., GEE, E. & PILLAI, S. (1993). Regulation of keratinocyte growth, differentiation, and vitamin D metabolism by analogs of 1,25-dihydroxyvitamin D. J. Invest. Dermatol., 101, 713-718.
7. BIKLE, D.D. & PILLAI, S. (1993). Vitamin D, calcium, and epidermal differentiation. Endocrinol. Rev., 14, 3-19.
8. 3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem. Pharmacol., 42, 1569-1575.
9. 2+-independent isoforms of protein kinase C in rat colonocytes. J. Clin. Invest., 95, 2215-2221.
10. BOUILLON, R., OKAMURA, W.H. & NORMAN, A.W. (1995). Structure-function relationships in the vitamin D endocrine system. Endocrinol. Rev., 16, 200-257.
11. BRAUCHE, M., ANGERMEYER, K., HUBNER, G. & WERNER, S. (1994). Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene, 9, 3199-3204.
12. CHEDID, M., RUBIN, J.S., CSAKY, K.G. & AARONSON, S.A. (1994). Regulation of keratinocyte growth factor gene expression by interleukin 1. J. Biol. Chem., 269, 10753-10757.
13. 3 are potentiated by epidermal growth factor and attenuated by insulin in cultured human keratinocytes. J. Invest. Dermatol., 104, 113-117.
14. COOK, P.W., PITTELKOW, M.R & SHIPLEY, G.D. (1991). Growth factor-independent proliferation of normal human neonatal keratinocytes: production of autocrine- and paracrine-acting mitogenic factors. J. Cell Physiol., 146, 277-289.
15. ELDER, J.T., FISHER, G.J., LINDQUIST, P.B., BENNETT, G.L., PITTELKOW, M.R., COFFEY, R.J., ELLINGSWORTH, L., DERYNCK, R. & VOORHEES, J.J. (1989). Overexpression of transforming growth factor α in psoriatic epidermis. Science, 243, 811-814.
16. ELDER, J.T., SARTOR, C.I., BOWMAN, D.K., BENRAZAVI, S., FISHER, G.J. & PITTELKOW, M.R. (1992). Interleukin-6 in psoriasis: expression and mitogenicity studies. Arch. Dermatol. Res., 284, 324-332.
17. GAVRIELI, Y., SHERMAN, Y. & BEN SASSON, S.A. (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119, 493-501.
18. GNIADECKI, R. (1994). A vitamin D analogue KH 1060 activates the protein kinase C - c-fos signalling pathway to stimulate epidermal proliferation in murine skin. J. Endocrinol., 143, 521-525.
19. 3: dependence on cell culture conditions. J. Invest. Dermatol., 106, 510-516.
20. 3 in normal human keratinocytes. J. Invest. Dermatol., 106, 1212-1217.
21. 3. Biochem. Pharmacol., 49, 621-624.
22. GOTTLIEB, A.B. (1990). Immunologic mechanisms in psoriasis. J. Invest. Dermatol., 95, 18S-19S.
23. GOTTLIEB, A.B., CHANG, C.K., POSNETT, D.N., FANELLI, B. & TAM, J.P. (1988). Detection of transforming growth factor α in normal, malignant, and hyperproliferative human keratinocytes. J. Exp. Med., 167, 670-675.
24. GUO, L., YU, Q.C. & FUCHS, E. (1993). Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. EMBO J., 12, 973-986.
25. HAAKE, A.R. & POLAKOWSKA, R.R. (1993). Cell death by apoptosis in epidermal biology. J. Invest. Dermatol., 101, 107-112.
26. HANSEN, K., CALVERLEY, M. & BINDERUP, L. (1991). Synthesis and biological activity of 22-oxa vitamin D analogues. In Vitamin D. Gene regulation, Structure-Function Analysis and Clinical Application, ed. Norman, A.W., Bouillon, R., & Thomasset, M. pp. 161-162. Berlin: Walter de Gruyter.
27. HINES, M.D. & ALLEN-HOFFMANN, B.L. (1996). Keratinocyte growth factor inhibits cross-linked envelope formation and nucleosomal fragmentation in cultured human keratinocytes. J. Biol. Chem., 271, 6245-6251.
28. 3. Endocrinology, 113, 1950-1957.
29. ITIN, P.H., PITTELKOW, M.R. & KUMAR, R. (1994). Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined in culture medium. Endocrinology, 135, 1793-1798.
30. JIANG, C.K., MAGNALDO, T., OHTSUKI, M., FREEDBERG, I.M., BERNERD, F. & BLUMENBERG, M. (1993). Epidermal growth factor and transforming growth factor alpha specifically induce the activation- and hyperproliferation-associated keratins 6 and 16. Proc. Natl. Acad. Sci. U.S.A., 90, 6786-6790.
31. JONES, P.H., HARPER, S. & WATT, F.M. (1995). Stem cell patterning and fate in human epidermis. Cell, 80, 83-93.
32. JONES, P.H. & WATT, F.M. (1993). Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell, 73, 713-724.
33. KHARE, S., WILSON, D.M., TIEN, X.-Y., DUDEJA, P.K., WALI, R.K., SITRIN, M.D. & BRASITUS, T.A. (1993). 1,25-Dihydroxycholecalciferol rapidly activates rat colonic particulate guanylate cyclase via a protein kinase C-dependent mechanism. Endocrinology, 133, 2213-2219.
34. 3 in CaCo-2 cells. Endocrinology, 135, 277-283.
35. 3 and calcipotriolenhance the secretion of transforming growth factor-beta 1 and -beta 2 in cultured murine keratinocytes. Growth Factors, 8, 153-163.
36. KRAGBALLE, K. (1992). Treatment of psoriasis with calcipotriol and other vitamin D analogues. J. Am. Acad. Dermatol., 27, 1001-1008.
37. KRAGBALLE, K., GJERTSEN, B.T., DE HOOP, D., KARLSMARK, T., VAN DE KERKHOK, P.C., LARKO, O., NIEBOER, C., ROED PETERSEN, J., STRAND, A. & TIKJOB, G. (1991). Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet, 337, 193-196.
38. KRANE, J.F., GOTTLIEB, A.B., CARTER, D.M. & KRUEGER, J.G. (1992). The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor. J. Exp. Med., 175, 1081-1090.
39. KRUEGER, J.G. & GOTTLIEB, A.B. (1994). Growth factors, cytokines, and eikosanoids. In Psoriasis, ed. Dubertret, L. pp. 18-44. Brescia: ISED.
40. MARCHESE, C., RUBIN, J., RON, D., FAGGIONI, A., TORRISI, M.R., MESSINA, A., FRATI, L. & AARONSON, S.A. (1990). Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J. Cell Physiol., 144, 326-332.
41. 3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J. Clin. Invest., 83, 1903-1915.
42. MISRA, P., NICKOLOFF, B.J., MORHENN, V.B., HINTZ, R.L. & ROSENFELD, R.G. (1986). Characterization of insulin-like growth factor-I/somatomedin-C receptors on human keratinocyte monolayers. J. Invest. Dermatol., 87, 264-267.
43. 3, a steroid hormone that produces biological effects via both genomic and non-genomic pathways. J. Steroid Biochem. Molec. Biol., 41, 231-240.
44. PITTELKOW, M.R., COOK, P.W., SHIPLEY, G.D., DERYNCK, R. & COFFEY, R.J. (1993). Autonomous growth of human keratinocytes requires epidermal growth factor receptor occupancy. Cell Growth Differ., 4, 513-521.
45. 3 stimulates specifically the last steps of epidermal differentiation of cultured human keratinocytes. Differentiation, 47, 173-188.
46. SACHSENMEIER, K.F., SHEIBANI, N., SCHLOSSER, S.J. & ALLEN-HOFFMANN, B.L. (1996). Transforming growth factor-β1 inhibits nucleosomal fragmentation in human keratinocytes following loss of adhesion. J. Biol. Chem., 271, 5-8.
47. 3 and calcium on growth and differentiation and on c-fos and p53 gene expression in normal human keratinocytes. J. Invest. Dermatol., 103, 323-329.
48. 3 evokes oscillations of intracellular calcium in a pancreatic β-cell line. Endocrinology, 136, 2852-2861.
49. 3. J. Biol. Chem., 270, 6639-6643.
50. 3 on the morphologic and biochemical and differentiation of cultured human keratinocytes grown in serum-free conditions. J. Invest. Dermatol., 86, 709-714.
51. STAIANO COICO, L., KRUEGER, J.G., RUBIN, J.S., D'LIMI, S., VALLAT, V.P., VALENTINO, L., FAHEY, T., HAWES, A., KINGSTON, G., MADDEN, M.R., MATHWICH, M., GOTTLIEB, A.B. & AARONSON, S.A. (1993). Human keratinocyte growth factor effects in a porcine model of epidermal wound healing. J. Exp. Med., 178, 865-878.
52. 3 potentiates the keratinocyte response to calcium. J. Biol. Chem., 269, 14723-14729.
53. TAMADA, Y., TAKAMA, H., KITAMURA, T., YOKOCHI, K., NITTA, Y., IKEYA, T. & MATSUMOTO, Y. (1994). Identification of programmed cell death in normal human skin tissues by using specific labelling of fragmented DNA. Br. J. Dermatol., 131, 521-524.
54. VAN DE KERKHOF, P.C.M. (1995). Biological activity of vitamin D analogues in the skin, with special reference to antispsoriatic mechanisms. Br. J. Dermatol., 132, 675-682.
55. 3 analog KH1060. Proc. Natl. Acad. Sci. U.S.A., 93, 10685-10690.
56. VASSAR, R. & FUCHS, E. (1991). Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation. Genes Dev., 5, 714-727.
57. WALTERS, M.R. (1992). Newly identified actions of the vitamin D endocrine system. Endocrinol. Rev., 13, 719-764.
58. WEISS, R.A., EICHNER, R. & SUN, T.-T. (1984). Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes. J. Cell Biol., 98, 1397-1406.
59. WERNER, S., PETERS, K.G., LONGAKER, M.T., FULLER PACE, F., BANDA, M.J. & WILLIAMS, L.T. (1992). Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc. Natl. Acad. Sci. U.S.A., 89, 6896-6900.
60. WILLE, J.J., JR., PITTELKOW, M.R., SHIPLEY, G.D. & SCOTT, R.E. (1994). Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: clonal analyses, growth kinetics and cell cycle studies. J Cell Physiol., 121, 31-44.